Home/Filings/4/0001209191-17-025201
4//SEC Filing

MEI Pharma, Inc. 4

Accession 0001209191-17-025201

$LITSCIK 0001262104operating

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 5:55 PM ET

Size

5.5 KB

Accession

0001209191-17-025201

Insider Transaction Report

Form 4
Period: 2017-04-03
Drazba Brian G.
Chief Financial Officer
Transactions
  • Award

    Option to purchase shares of common stock

    2017-04-03+150,000150,000 total
    Exercise: $1.59Exp: 2027-04-03Common Stock par value $0.00000002 (150,000 underlying)
Footnotes (1)
  • [F1]One-quarter of the options will vest on April 3, 2018; the remaining three-quarters of the options will vest in equal monthly installments over the following thirty-six months.

Issuer

MEI Pharma, Inc.

CIK 0001262104

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001262104

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 5:55 PM ET
Size
5.5 KB